The plasma growth hormone (GH) response to direct stimulation with growth hormone-releasing hormone (GHRH) before and after a standard meal was investigated in 14 polycystic ovarian syndrome (PCOS) subjects. Data were compared with those obtained from 14 healthy normovulatory matched patients. All women underwent an oral glucose tolerance test (OGTT) (75 g) and basal plasma hormone concentrations were evaluated. On a different day all subjects had a GHRH test (50 µg GHRH) both before and after lunch randomly. In obese PCOS subjects the GH response to GHRH was blunted after a meal, while in obese control patients there was an enhanced response of GH to GHRH after a meal. Normal control subjects showed an inhibition of the GH response after feeding and lean PCOS subjects showed a trend toward an augmented GHRH related secretion after a meal significantly higher than normal controls (P < 0.05) but not significantly higher than the pre-prandial response. In conclusion, the data indicate in PCOS a derangement of GH secretion related to food ingestion; in particular obese PCOS patients did not exhibit any change of GH response after a meal compared with the paradoxical response observed in obese controls. Several other factors beyond body mass index and hyperinsulinism could be involved in these pathophysiological events.
Introduction
hyperandrogenism and in a considerable percentage of subjects by obesity and hyperinsulinism. The blunted GH response to The debate on the physiological regulation of growth hormone GHRH in PCOS women could be related only partially to (GH) secretion is still open and several aspects remain to be obesity since lean hyperinsulinaemic subjects showed a similar elucidated. It is well known that GH secretion is blunted in reduction of GH secretion after GHRH administration (Lanzone obesity (Williams et al., 1984) . Moreover, other metabolic et al., 1995) , thus indicating that several other factors may signals may modify the GH response to GH-releasing hormone interfere with GH secretion. (GHRH): in normal subjects the plasma GH response to GHRH
The aim of the present study was to investigate the plasma was impaired after an infusion of glucose (Sharp et al., 1984) ; GH response to direct stimulation with GHRH before and after similarly lipid-heparin administration, by inducing an increase a standard meal in PCOS subjects in order to study the in circulating free fatty acid (FFA) concentrations, also blunted influence of body weight and insulin on GH secretion. such response (Imaki et al., 1985) . Our previous studies provided information about the meal interference on GH response to GHRH in normal and in obese subjects (De Materials and methods Marinis et al., 1988) ; particularly, obese patients exhibited a A total of 14 women affected by PCOS were studied. Seven of them paradoxical increase of GH to GHRH in relation to food were obese and seven normal weight. All of the women were in good ingestion as compared with controls, in whom an inhibitory health and euthyroid, and none had taken any medication known to effect was observed. , 1995) . This syndrome is characterized by anovulation, amenorrhoea or oligoamenorrhoea and hirsutism), plasma androgen commercial kits from Radim. Intra-assay and inter-assay coefficients of variation were respectively 2.5% and 5.8%. The lowest amount of concentrations at the upper limit or above the normal range (androstenedione 1.98-5.58 nmol/l, testosterone 0.58-2.01 nmol/l), and bilateral GH detected was 0.04 µg/l. Free fatty acids were determined by an acyl-coenzyme-A oxidase based colorimetric method (Okabe normal or enlarged ovaries with the presence of at least 10 microcysts (2-8 mm diameter) (from the inner margin to the outer margin in et al., 1980) . longitudinal cross-sections) associated with an increase in ovarian Data analysis stroma (Polson et al., 1988) at the time of ultrasonography. A normal An abnormal glycaemic response to the OGTT was defined LH to FSH ratio was not considered an exclusion criterion. Data were according to the criteria of National Diabetes Data Group (National compared with those obtained from 14 health normovulatory patients, Diabetes Group, 1994) . No patient showed impaired glucose tolerance. matched for age and body mass index (BMI), seven simply obese All results were presented as mean Ϯ SD. Insulin and GH plasma patients (i.e. not PCOS) were recruited to our endocrinology department concentrations were also expressed as area under the curve (AUC) and seven lean controls to our sterility centre. Obesity was defined as a after OGTT or GHRH test respectively, calculated by the trapezoidal BMI Ͼ 27 kg/m 2 (normal range 19-25 kg/m 2 ). All subjects underwent rule and expressed as µIU/mlϫ240 min for insulin (AUC-I) and the same clinical protocol. Informed consent was obtained from each µg/lϫ120 min for GH. Incremental area under curve for GH patient. The study was approved by our ethical committee. In the (AUCi-GH) was calculated by trapezoidal rule after subtracting basal follicular phase, women were hospitalized the day before the beginning hormone concentration. The difference (AUCd-GH) between the of the basal study: this last one was performed after a 3 day standard GHRH elicited incremental pre-prandial and post-prandial area carbohydrate diet (300 g) and fasting overnight. At 0700 h blood (AUCd-GH ϭ AUCi post-prandial -AUCi-GH pre-prandial) was samples were taken for evaluation of LH, FSH, 17β-oestradiol, 17-considered as indicator of GH secretion capacity in relation to a meal. hydroxyprogesterone (17-OHP), sex hormone-binding globulin
The ratio of testosteroneϫ100/SHBG was used to calculate the free (SHBG), dehydroepiandrosterone sulphate (DHEA-S), androsteneandrogen index (FAI). The distribution of the data was tested by dione, testosterone, growth hormone (GH), insulin, glucose, and free Kolmogorov-Smirnov test to verify whether the samples came from fatty acid (FFA) plasma concentrations.
a specified distribution and it was found that the data were not Then all women had an oral glucose tolerance test (OGTT). Blood normally distributed. The significance of differences between the samples were collected every 30 min for 4 h after ingestion of 75 g same tests performed before and after a meal was assessed by the of glucose; insulin and glucose were assayed in each sample. On non-parametric Wilcoxon rank-sum test. The comparison between different days all subjects underwent GHRH (50 µg GHRH; Geref, different study groups was performed by the non-parametrical MannSerono, Italy) tests both before and after lunch in randomized order.
Whitney U-test. Linear regression analysis was used to analyse Pre-prandial tests possible correlation between endocrine findings. The level of statistical significance was set at P Ͻ 0.05. After an overnight fast the women had their usual breakfast at 0800 h and they ate nothing thereafter until the last test. At 1245 h, while the women were resting in a quiet room, an indwelling venous Results cannula was inserted in one arm, through which normal saline (0.9%) Table I lists the endocrine and metabolic parameters for obese was given slowly. At time 0 (1300 h) a 50 µg bolus dose of GHRH and lean groups of PCOS and normal subjects.
was injected i.v. Blood samples were collected 15 min and just before and 30, 60, 90 and 120 min after GHRH administration.
Obese PCOS patients showed the lowest SHBG values and their androstenedione and LH plasma concentrations were Post-prandial tests greater than those found both in lean PCOS and control groups.
Fasting throughout the night the women had their usual breakfast at Lean control subjects showed the lowest FAI index and the 0800 h and then ate nothing until the last test. At 1200 h the women lowest FFA concentration in comparison with other groups ate a 800 kcal meal composed of 55% carbohydrate, 30.6% lipid, (P Ͻ 0.01 and P Ͻ 0.05 respectively). and 13.6% protein, as previously described (De Marinis et al., 1991) .
Fasting insulin concentrations were significantly higher in A saline infusion was started at 1245 h and GHRH (50 µg) was the obese PCOS group and in obese controls with respect to administered 15 min later (time 1300 h). Blood samples were collected those found in lean controls (P Ͻ 0.01). Moreover, 0, 30, 60, 90 and 120 min. concentrations in obese PCOS patients were significantly higher than in the other groups (P Ͻ 0.001). No differences Assays were found among groups for fasting glycaemia and AUCAll blood samples were promptly centrifuged (1500 r.p.m.) and stored glucose values.
at -20°C until assayed. LH, FSH, oestradiol, testosterone, 17-OHP, androstenedione, DHEA-S and SHBG were determined in the basal Obese patients (both PCOS and controls) had lower baseline condition. These hormones were measured in duplicate by radio-GH values versus lean PCOS and control subjects (P Ͻ 0.01).
immunoassay methods using commercial kits (Radim, Pomezia, Italy).
Figure 1 shows plasma GH concentrations after GHRH
The immunoradiometric assay (IRMA) on solid phase (coated tube), administration before and after a meal both in lean and obese based on monoclonal double-antibody technique, was used for LH, control and PCOS subjects.
FSH and SHBG. Steroids were assayed by a radioimmunoassay direct method in human serum or plasma. Insulin was assayed using Pre-prandial test radioimmunoassay methods and glucose concentrations were deterIn controls the mean peak plasma GH response to GHRH mined by the glucose oxidase technique. Intra-assay and inter-assay occurred between 30 and 60 min after GHRH injection. In the coefficients of variation were as follows: LH, 5.6% and 9.1%; obese women the mean peak plasma GH concentration was FSH, 6 .9% and 8.4%; oestradiol, 2.3% and 3.5%; testosterone and markedly lower than the peak concentration in normal women androstenedione, 6.1% and 9.3%; insulin, 5.1% and 6.2%; SHBG, 6.9% and 8.5%. GH was determined by the IRMA method using (5.99 Ϯ 2.71 versus 38.7 Ϯ 13.21 µg/l; P Ͻ 0.01). In lean PCOS subjects GH peak reached 12.3 Ϯ 9.2 µg/l (P Ͻ 0.001; r ϭ -0.87) as well as AUC-I values (P Ͻ 0.001; r ϭ -0.813) was found in the whole PCOS group. However values significantly lower than lean controls (P Ͻ 0.05). However, GH concentrations remained significantly higher in controls a correlation was found between BMI and AUCd-GH (P Ͻ 0.05; r ϭ 0.55) but no correlation between AUC-I than those observed in PCOS obese patients at 60, 90 and 120 min (P Ͻ 0.05).
and AUCd-GH.
Post-prandial test
Discussion At 1300 h, 1 h after a meal, lean control subjects showed GHRH-induced GH peak concentrations significantly lower Body weight and nutritional status are two factors involved in GH secretion and GH response to provocative stimulation (10.7 Ϯ 3.84 µg/l; P Ͻ 0.05) than that observed in preprandial tests. In obese patients plasma GH response to GHRH (Tanaka et al., 1990; Gianotti et al., 1998) . The results presented here concerning obese and lean control subjects are injection was significantly increased at 30 min after GHRH injection and the peak GH response was significantly higher in in agreement with those previously described (De Marinis et al., 1988) . In fact in obese fasting women GHRH was less comparison with the one registered without meal administration (14.84 Ϯ 4.95 µg/l; P Ͻ 0.05).
effective in causing an increment in plasma GH concentrations than in normal fasting women. Furthermore lean controls The plasma GH response to GHRH in lean PCOS subjects increased in respect to pre-prandial response but not showed an inhibition of the GH response after feeding, whereas the obese women had greater plasma GH concentration significantly, otherwise the GH post-prandial peak in these subjects was significantly higher than the GH post-prandial responses when tested after a meal, compared with those in the fasting state. The data presented here showed that this peak in normal subjects (23.6 Ϯ 11 µg/l, P Ͻ 0.05). In the obese PCOS subjects the GH plasma peak was significantly 'paradoxical' response to GHRH after a meal is absent in PCOS population and, on the contrary, obese patients demonstrated a lower than in lean PCOS women and GH plasma concentrations at 30, 60, 90 and 120 min were not significantly different from persistent state of GH-releasing inability. Several authors indicated that obesity is associated with an those before lunch.
To explore the relative influence of BMI and insulin on abnormal elevation in both fasting and post-prandial FFA concentration (Dieguez and Casanueva, 1995; Cordido et al., GHRH-induced GH secretion the correlation of these parameters with the difference in GH incremental area after and 1998). Previous studies demonstrated that a glucose infusion or a rise in plasma FFA concentrations impaired GH responsivebefore a meal (AUCd-GH) was examined. A significantly negative linear correlation between AUCd-GH values and BMI ness to GHRH (Sharp et al., 1984; Imaki et al., 1985) . Such negative feedback of FFA on GH release may occur both at GHRH has been observed, whereas during hypoglycaemic insulin clamp the GH response to hypoglycaemia is inversely the pituitary and hypothalamic level (Pontiroli et al., 1986 ). In the current study, a primary role of FFA seems to be related to the degree of hyperinsulinaemia (Diamond et al., 1991; Press et al., 1992) . Recently it has been demonstrated excluded. Obese controls as well as lean PCOS subjects showed an augmented GH secretion after a meal despite higher that insulin, independently of FFA, is able to exert an inhibitory effect on GH release (Lanzi et al., 1997) . basal plasma FFA.
Certainly BMI is correlated with GH-stimulated secretion Thus insulin negative feedback may have physiological relevance, because the insulin concentrations, able to reduce after a meal in PCOS and in the control population. Therefore body weight per se is an important but not the only factor GH response to GHRH, are commonly observed during the post-prandial period. Therefore, elevated insulin concentrations responsible for blunting GHRH-induced release.
In this concern the relation between AUC-I and AUCd-GH can inhibit pituitary GH release and insulin resistance may be involved in the alteration of GH secretion, particularly in obese is present only in the PCOS population, where the PCOS obese patients showed the highest AUC-I values in respect to PCOS patients. In the attempt to explain the different behaviour between lean PCOS patients and also to obese control patients.
The role of insulin is less established and needs to be studied controls and hyperandrogenized PCOS subjects the influence of hormonal milieu on GH secretion could be considered. further. Several pieces of experimental data suggest a possible direct effect of insulin on GH axis; for instance, insulin Some studies have demonstrated that steroid environment may affect GH dynamics and higher androgen concentrations could receptors are present in rat hypothalamus and insulin binding sites have been demonstrated in normal rat pituitary adenoma modify the sensitivity to regulatory stimuli Kaltsas et al., 1998) . cells as well as in human pituitary adenoma cells (Ceda et al., 1985; Schwartz et al., 1991) . In-vitro studies demonstrate that Moreover since previous work indicated that opioids are involved in the post-prandial GH increase in normal subjects insulin is able to inhibit the peripheral action of GH (Ji et al., 1999) . In normal subjects integrated 24 h GH concentration is (De Marinis et al., 1989) and it was suggested that derangement of opioid tone may have some relation with the blunted elevated during fasting (Ho et al., 1988) ; moreover, during euglycaemic insulin clamp, a reduction of GH response to response of GH to GHRH in PCOS (Villa et al., 1997), it may
